SUZANNE IRVAN: Open Payments
NPI 1841712353 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 40 payments from 13 companies in 2025. Trend: 2023 $39 · 2024 $277 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $160 |
| Axsome Therapeutics, Inc. | 7 | $124 |
| Amgen Inc. | 7 | $109 |
| Lilly USA, LLC | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Novo Nordisk Inc | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: REXULTI, Auvelity, OTEZLA, CAPLYTA, MOUNJARO, Wegovy, Kerendia, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
